ITRIZOLE Side Effects

6985664-0 | Interstitial Lung Disease, Melaena, Oesophageal Carcinoma
on Sep 08, 2010 Male patient from JAPAN , weighting 114.6 lb, was diagnosed with oral candidiasis, gastric ulcer, gastritis, cancer pain, vomiting and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, melaena, oesophageal carcinoma. Itrizole dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), OXINORM (View Oxinorm Review and Oxinorm Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), LOXONIN (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6980183-X | Nail Discolouration, Pseudomonas Infection
Patient was taking Itrizole (View Usage). Patient had the following side effects: nail discolouration, pseudomonas infection on Sep 09, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with onychomycosis and. Itrizole dosage: .

6978259-6 | Hepatic Function Abnormal, Renal Impairment
Adverse event was reported on Sep 06, 2010 by a Female patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with systemic mycosis, prophylaxis and. Location: JAPAN , weighting 92.59 lb, After Itrizole was administered, patient had the following side effects: hepatic function abnormal, renal impairment. During the same period patient was treated with UNASYN (View Unasyn Review and Unasyn Label ), DALACIN (View Dalacin Review and Dalacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MEROPENEM TRIHYDRATE (View Meropenem Trihydrate Review and Meropenem Trihydrate Label ).

6970574-5 | Nail Discolouration, Pseudomonas Infection
on Aug 19, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with onychomycosis and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: nail discolouration, pseudomonas infection. Itrizole dosage: .


6967191-X | Enanthema, Laryngeal Oedema, Pruritus, Pyrexia, Stevens-johnson Syndrome
on Aug 25, 2010 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with onychomycosis and was treated with Itrizole (View Usage). Patient had the following side effects: enanthema, laryngeal oedema, pruritus, pyrexia, stevens-johnson syndrome. Itrizole dosage: . Patient was hospitalized.

6962490-X | Renal Impairment, White Blood Cell Count Decreased
Patient was taking Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: renal impairment, white blood cell count decreased on Aug 24, 2010 from JAPAN Additional patient health information: Male patient , weighting 13.89 lb, was diagnosed with antifungal prophylaxis, sepsis (What is sepsis?), graft versus host disease and. Itrizole dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), PROGRAF (View Prograf Review and Prograf Label ).

6962488-1 | Dermatitis Exfoliative, Immune System Disorder, Pneumonia, Renal Failure Chronic
Adverse event was reported on Aug 27, 2010 by a Female patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with pneumonia bacterial, neuropathy peripheral, hyperphosphataemia and. Location: JAPAN , weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, immune system disorder, pneumonia (What is pneumonia?), renal failure chronic. During the same period patient was treated with MEROPENEM TRIHYDRATE (View Meropenem Trihydrate Review and Meropenem Trihydrate Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), RENAGEL (View Renagel Review and Renagel Label ).

6962487-X | Acute Myeloid Leukaemia, Disease Progression, Fluid Retention, Insomnia, Liver Disorder, Vitamin K Deficiency
on Aug 24, 2010 Male patient from JAPAN , weighting 101.4 lb, was diagnosed with respiratory moniliasis, pulmonary mycosis, pneumonia bacterial, gastric ulcer haemorrhage, depression (What is depression?), acute myeloid leukaemia and was treated with Itrizole (View Usage). Patient had the following side effects: acute myeloid leukaemia, disease progression, fluid retention, insomnia, liver disorder, vitamin k deficiency. Itrizole dosage: . During the same period patient was treated with MICONAZOLE NITRATE (View Miconazole Nitrate Review and Miconazole Nitrate Label ), MAXIPIME (View Maxipime Review and Maxipime Label ), OMEPRAL (View Omepral Review and Omepral Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), LASTET (View Lastet Review and Lastet Label ).

6940211-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hypernatraemia, Hypokalaemia
on Aug 16, 2010 Male patient from JAPAN , 31 years of age, was diagnosed with fungaemia, graft versus host disease, gastritis, bronchitis chronic and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hypernatraemia, hypokalaemia. Itrizole dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), OMEPRAL (View Omepral Review and Omepral Label ), ZOSYN (View Zosyn Review and Zosyn Label ).

6934185-X | Bronchopulmonary Aspergillosis, Hypochloraemia, Hyponatraemia, Interstitial Lung Disease, Respiratory Failure
Patient was taking Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, hypochloraemia, hyponatraemia, interstitial lung disease, respiratory failure on Aug 16, 2010 from JAPAN Additional patient health information: Male patient , weighting 110.2 lb, was diagnosed with bronchopulmonary aspergillosis, gastric ulcer, pneumonia (What is pneumonia?), interstitial lung disease, hypovitaminosis and. Itrizole dosage: . During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), FIRSTCIN (View Firstcin Review and Firstcin Label ), PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), VITAMEDIN (View Vitamedin Review and Vitamedin Label ).

6916895-3 | Atrial Fibrillation, Blood Urea Decreased, Cardiac Failure, Dyspnoea, Epistaxis, Hypochloraemia, Hyponatraemia, Insomnia
Adverse event was reported on Aug 02, 2010 by a Female patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with penicilliosis, bronchopulmonary aspergillosis, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , weighting 83.78 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood urea decreased, cardiac failure, dyspnoea, epistaxis, hypochloraemia, hyponatraemia, insomnia. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6916894-1 | Aspergillosis, Atypical Mycobacterial Infection, Cough, Respiratory Failure
on Aug 02, 2010 Female patient from JAPAN , weighting 83.78 lb, was diagnosed with atypical mycobacterial infection, depression (What is depression?), pyrexia and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: aspergillosis, atypical mycobacterial infection, cough, respiratory failure. Itrizole dosage: . During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), KLARICID (View Klaricid Review and Klaricid Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6911339-X | Atrial Fibrillation, Blood Urea Decreased, Cardiac Failure, Dyspnoea, Epistaxis, Hypochloraemia, Hyponatraemia, Insomnia
on Aug 02, 2010 Female patient from JAPAN , weighting 83.78 lb, was diagnosed with penicilliosis, bronchopulmonary aspergillosis, atrial fibrillation (What is atrial fibrillation?) and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood urea decreased, cardiac failure, dyspnoea, epistaxis, hypochloraemia, hyponatraemia, insomnia. Itrizole dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6900640-1 | Blood Pressure Increased, Intraocular Pressure Increased, Nausea, Sensation Of Heaviness
Patient was taking Itrizole (View Usage). Patient had the following side effects: blood pressure increased, intraocular pressure increased, nausea (What is nausea?), sensation of heaviness on Jul 23, 2010 from JAPAN Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with onychomycosis, glaucoma (What is glaucoma?), hypertension and. Itrizole dosage: . During the same period patient was treated with BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), CONIEL (View Coniel Review and Coniel Label ), RENIVACE (View Renivace Review and Renivace Label ).

6894169-7 | Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Decreased Appetite, Pyrexia
Adverse event was reported on Jul 26, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with interstitial lung disease, prophylaxis, arrhythmia (What is arrhythmia?), cardiac failure chronic and. Location: JAPAN , weighting 116.8 lb, After Itrizole was administered, patient had the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, pyrexia. During the same period patient was treated with ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), ASPENON (View Aspenon Review and Aspenon Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), AZOSEMIDE (View Azosemide Review and Azosemide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6878370-4 | Blood Glucose Increased, Sluggishness
on Jul 20, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with onychomycosis and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, sluggishness. Itrizole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6878368-6 | Blood Glucose Increased, Sluggishness
on Jul 20, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with onychomycosis and was treated with Itrizole (View Usage). Patient had the following side effects: blood glucose increased, sluggishness. Itrizole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6871338-3 | Interstitial Lung Disease
Patient was taking Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: interstitial lung disease on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with oral candidiasis and. Itrizole dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6863291-3 | Neutrophil Count Decreased, Pneumonia, White Blood Cell Count Increased
Adverse event was reported on Jul 16, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) . Location: JAPAN , weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: neutrophil count decreased, pneumonia (What is pneumonia?), white blood cell count increased. During the same period patient was treated with MYCOSYST (View Mycosyst Review and Mycosyst Label ), MAXIPIME (View Maxipime Review and Maxipime Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6835313-7 | Altered State Of Consciousness, Haemoglobin Decreased, Herpes Zoster, Hypokalaemia, Hyponatraemia, Multiple Myeloma, Platelet Count Decreased, Renal Failure Acute
on Jul 07, 2010 Female patient from JAPAN , weighting 154.3 lb, was diagnosed with prophylaxis, herpes zoster, multiple myeloma (What is multiple myeloma?), renal impairment and was treated with Itrizole (View Usage). Patient had the following side effects: altered state of consciousness, haemoglobin decreased, herpes zoster, hypokalaemia, hyponatraemia, multiple myeloma (What is multiple myeloma?), platelet count decreased, renal failure acute. Itrizole dosage: . During the same period patient was treated with VALTREX (View Valtrex Review and Valtrex Label ), DECADRON (View Decadron Review and Decadron Label ), LASIX (View Lasix Review and Lasix Label ), COTRIM (View Cotrim Review and Cotrim Label ), VELCADE (View Velcade Review and Velcade Label ).

6831208-3 | Blood Pressure Fluctuation, Body Temperature Decreased, Phlebitis
on Jul 05, 2010 Male patient from JAPAN , weighting 134.4 lb, was diagnosed with cerebral infarction, hypertension and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: blood pressure fluctuation, body temperature decreased, phlebitis. Itrizole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), MYONAL (View Myonal Review and Myonal Label ), ATELEC (View Atelec Review and Atelec Label ), METHYCOBAL (1500 Microgram) (View Methycobal Review and Methycobal Label ), FRANDOL (View Frandol Review and Frandol Label ).

6817538-X | Herpes Zoster
Patient was taking Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: herpes zoster on Jun 30, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), pneumocystis jiroveci pneumonia and. Itrizole dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), ALKERAN (View Alkeran Review and Alkeran Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6816846-6 | Enanthema, Laryngeal Oedema, Pruritus, Pyrexia, Stevens-johnson Syndrome
Adverse event was reported on Jun 30, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: JAPAN , weighting 154.3 lb, Patient had the following side effects: enanthema, laryngeal oedema, pruritus, pyrexia, stevens-johnson syndrome. Patient was hospitalized.

6816797-7 | Interstitial Lung Disease
on Jun 30, 2010 Male patient from JAPAN , 76 years of age, was diagnosed with oral candidiasis and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: interstitial lung disease. Itrizole dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6816796-5 | Viith Nerve Paralysis
on Jun 28, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with onychomycosis, viith nerve paralysis and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: viith nerve paralysis. Itrizole dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6816795-3 | Herpes Zoster
Patient was taking Itrizole (View Usage). Patient had the following side effects: herpes zoster on Jun 26, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Itrizole dosage: . During the same period patient was treated with ALKERAN (View Alkeran Review and Alkeran Label ), PREDONINE (View Predonine Review and Predonine Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6801038-7 | Acute Myeloid Leukaemia, Blood Lactate Dehydrogenase Increased, Electrolyte Imbalance, Hepatic Function Abnormal, Hypertension, Neutrophil Percentage Decreased, Renal Impairment, White Blood Cell Count Decreased
Adverse event was reported on Jun 23, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with febrile neutropenia, hypokalaemia and. Location: JAPAN , weighting 94.80 lb, After Itrizole was administered, patient had the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, electrolyte imbalance, hepatic function abnormal, hypertension, neutrophil percentage decreased, renal impairment, white blood cell count decreased. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), TARGOCID (View Targocid Review and Targocid Label ), POTASSIUM ASPARTATE (View Potassium-aspartate Review and Potassium-aspartate Label ).

6794563-9 | Altered State Of Consciousness, Haemoglobin Decreased, Herpes Zoster, Hypokalaemia, Hyponatraemia, Multiple Myeloma, Platelet Count Decreased, Renal Failure Acute
on Jan 22, 2009 Female patient from JAPAN , weighting 154.3 lb, was diagnosed with prophylaxis, herpes zoster, multiple myeloma (What is multiple myeloma?), renal impairment and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, haemoglobin decreased, herpes zoster, hypokalaemia, hyponatraemia, multiple myeloma (What is multiple myeloma?), platelet count decreased, renal failure acute. Itrizole dosage: . During the same period patient was treated with VALTREX (View Valtrex Review and Valtrex Label ), DECADRON (View Decadron Review and Decadron Label ), LASIX (View Lasix Review and Lasix Label ), COTRIM (View Cotrim Review and Cotrim Label ), VELCADE (View Velcade Review and Velcade Label ).

6785961-8 | Blood Pressure Increased, Intraocular Pressure Increased, Nausea, Sensation Of Heaviness
on Jun 16, 2010 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with onychomycosis, glaucoma (What is glaucoma?), hypertension and was treated with Itrizole (View Usage). Patient had the following side effects: blood pressure increased, intraocular pressure increased, nausea (What is nausea?), sensation of heaviness. Itrizole dosage: . During the same period patient was treated with BENIDIPINE HYDROCHLORIDE (View Benidipine Hydrochloride Review and Benidipine Hydrochloride Label ), LOSARTAN (View Losartan Review and Losartan Label ), CONIEL (View Coniel Review and Coniel Label ), RENIVACE (View Renivace Review and Renivace Label ).

6784465-6 | Conjunctival Hyperaemia, Oedema Mouth, Pyrexia
Patient was taking Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: conjunctival hyperaemia, oedema mouth, pyrexia on Jun 14, 2010 from JAPAN Additional patient health information: Male patient , weighting 209.4 lb, was diagnosed with onychomycosis and. Itrizole dosage: . Patient was hospitalized.

6783234-0 | Diarrhoea, Disease Progression
Adverse event was reported on Jun 18, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with aspergillosis and. Location: JAPAN , 91 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, disease progression. During the same period patient was treated with MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ).

6780924-0 | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiogenic Shock, Multi-organ Failure, Renal Failure Acute, Sepsis
on Jun 17, 2010 Male patient from JAPAN , 68 years of age, weighting 81.57 lb, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Itrizole (View Usage). Patient had the following side effects: blood pressure decreased, cardiac failure congestive, cardiogenic shock, multi-organ failure, renal failure acute, sepsis (What is sepsis?). Itrizole dosage: Three 50 Mg Tablets Once Daily. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6774162-5 | Enanthema, Laryngeal Oedema, Pruritus, Stevens-johnson Syndrome
on Jun 11, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with onychomycosis and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: enanthema, laryngeal oedema, pruritus, stevens-johnson syndrome. Itrizole dosage: . Patient was hospitalized.

6774161-3 | Aspergillosis, Atypical Mycobacterial Infection, Cough, Respiratory Failure
Patient was taking Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, atypical mycobacterial infection, cough, respiratory failure on Jun 08, 2010 from JAPAN Additional patient health information: Female patient , weighting 83.78 lb, was diagnosed with atypical mycobacterial infection, depression (What is depression?), pyrexia and. Itrizole dosage: . During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), KLARICID (View Klaricid Review and Klaricid Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), HYPEN (View Hypen Review and Hypen Label ). Patient was hospitalized.

6761946-2 | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiogenic Shock, Renal Failure Acute
Adverse event was reported on Jun 08, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: Three 50 Mg Tablets Once Daily) was diagnosed with aspergillosis, bronchopulmonary aspergillosis and. Location: JAPAN , 68 years of age, weighting 81.57 lb, Patient had the following side effects: blood pressure decreased, cardiac failure congestive, cardiogenic shock, renal failure acute. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6760678-4 | Chronic Lymphocytic Leukaemia, Hypoglycaemia, Tonic Convulsion, Vomiting
on Jun 04, 2010 Female patient from JAPAN , weighting 85.98 lb, was diagnosed with pneumonia cytomegaloviral and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: chronic lymphocytic leukaemia, hypoglycaemia, tonic convulsion, vomiting. Itrizole dosage: .

6759755-3 | Face Oedema, Oedema Peripheral, Weight Increased
on May 31, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with oesophageal candidiasis and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, oedema peripheral, weight increased. Itrizole dosage: .

6758140-8 | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiogenic Shock, Renal Failure Acute
Patient was taking Itrizole (View Usage). Patient had the following side effects: blood pressure decreased, cardiac failure congestive, cardiogenic shock, renal failure acute on Jun 03, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 81.57 lb, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and. Itrizole dosage: Three 50 Mg Tablets Once Daily. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6757631-3 | Blood Creatinine Increased, Blood Potassium Decreased, Blood Pressure Diastolic Decreased, Blood Pressure Systolic Increased, Blood Urea Increased, C-reactive Protein Increased, Cardiac Failure, Cardiomyopathy, Cough
Adverse event was reported on Jun 03, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with bronchopulmonary aspergillosis, hyperlipidaemia, emphysema, hypertension and. Location: JAPAN , weighting 167.6 lb, After Itrizole was administered, patient had the following side effects: blood creatinine increased, blood potassium decreased, blood pressure diastolic decreased, blood pressure systolic increased, blood urea increased, c-reactive protein increased, cardiac failure, cardiomyopathy (What is cardiomyopathy?), cough. During the same period patient was treated with ROXATIDINE ACETATE HCL (View Roxatidine Acetate Hcl Review and Roxatidine Acetate Hcl Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ). Patient was hospitalized.

6757630-1 | Enanthema, Laryngeal Oedema, Stevens-johnson Syndrome
on May 28, 2010 Male patient from JAPAN , 70 years of age, was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: enanthema, laryngeal oedema, stevens-johnson syndrome. Itrizole dosage: . Patient was hospitalized.

6756761-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hypernatraemia
on May 27, 2010 Male patient from JAPAN , 31 years of age, was diagnosed with fungaemia, graft versus host disease, gastritis, bronchitis chronic and was treated with Itrizole (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hypernatraemia. Itrizole dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), OMEPRAL (View Omepral Review and Omepral Label ), ZOSYN (View Zosyn Review and Zosyn Label ).

6755524-9 | Hypokalaemia, Lung Disorder
Patient was taking Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: hypokalaemia, lung disorder on Jun 01, 2010 from JAPAN Additional patient health information: Male patient , weighting 125.7 lb, . Itrizole dosage: . During the same period patient was treated with MUCODYNE (View Mucodyne Review and Mucodyne Label ), MEDICON (View Medicon Review and Medicon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), BROCIN CODEINE (View Brocin Codeine Review and Brocin Codeine Label ).

6755508-0 | Blood Creatine Phosphokinase Increased, Decreased Appetite, Gastrointestinal Disorder, Malaise, Vomiting
Adverse event was reported on May 28, 2010 by a Female patient taking Itrizole (View Usage) (Dosage: ) was diagnosed with onychomycosis, diabetes mellitus, hyperlipidaemia, constipation (What is constipation?) and. Location: JAPAN , weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, decreased appetite, gastrointestinal disorder, malaise, vomiting. During the same period patient was treated with NOVOLIN R (View Novolin R Review and Novolin R Label ), FLUVASTATIN SODIUM (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), LACTOMIN (View Lactomin Review and Lactomin Label ).

6748662-8 | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiogenic Shock, Renal Failure Acute
on May 27, 2010 Male patient from JAPAN , 68 years of age, weighting 81.57 lb, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Itrizole (View Usage). Patient had the following side effects: blood pressure decreased, cardiac failure congestive, cardiogenic shock, renal failure acute. Itrizole dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6745521-1 | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiogenic Shock, Renal Impairment
on May 20, 2010 Male patient from JAPAN , 68 years of age, weighting 81.57 lb, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: blood pressure decreased, cardiac failure congestive, cardiogenic shock, renal impairment. Itrizole dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), DOBUTAMINE HYDROCHLORIDE (View Dobutamine Hydrochloride Review and Dobutamine Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PAZUCROSS (View Pazucross Review and Pazucross Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6743078-2 | Erythema
Patient was taking Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: erythema on May 21, 2010 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with onychomycosis and. Itrizole dosage: . During the same period patient was treated with LULICONAZOLE (View Luliconazole Review and Luliconazole Label ).

6739308-3 | Neutrophil Count Decreased, White Blood Cell Count Increased
Adverse event was reported on May 21, 2010 by a Male patient taking Itrizole (View Usage) (Dosage: ) . Location: JAPAN , weighting 141.1 lb, Patient had the following side effects: neutrophil count decreased, white blood cell count increased. During the same period patient was treated with MYCOSYST (View Mycosyst Review and Mycosyst Label ), MAXIPIME (View Maxipime Review and Maxipime Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6733288-2 | Face Oedema, Oedema Peripheral, Weight Increased
on May 13, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with oesophageal candidiasis and was treated with Itrizole (View Usage). After Itrizole was administered, patient had the following side effects: face oedema, oedema peripheral, weight increased. Itrizole dosage: .

6725937-X | Acute Myeloid Leukaemia, Disease Progression, Fluid Retention, Insomnia, Liver Disorder, Vitamin K Deficiency
on May 11, 2010 Male patient from JAPAN , weighting 101.4 lb, was diagnosed with respiratory moniliasis, pulmonary mycosis, pneumonia bacterial, gastric ulcer haemorrhage, depression (What is depression?), acute myeloid leukaemia and was treated with Itrizole (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, disease progression, fluid retention, insomnia, liver disorder, vitamin k deficiency. Itrizole dosage: . During the same period patient was treated with MICONAZOLE NITRATE (View Miconazole Nitrate Review and Miconazole Nitrate Label ), MAXIPIME (View Maxipime Review and Maxipime Label ), OMEPRAL (View Omepral Review and Omepral Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), LASTET (View Lastet Review and Lastet Label ).

6721853-8 | Erythema
Patient was taking Itrizole (View Usage). Patient had the following side effects: erythema on May 06, 2010 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with onychomycosis and. Itrizole dosage: . During the same period patient was treated with LULICONAZOLE (View Luliconazole Review and Luliconazole Label ).